AVAX TECHNOLOGIES INC
SC 13G, 1998-02-17
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: AVAX TECHNOLOGIES INC, SC 13G, 1998-02-17
Next: IMARK TECHNOLOGIES INC, 10QSB, 1998-02-17




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934

                            AVAX TECHNOLOGIES, INC.
              ----------------------------------------------------
                                (Name of Issuer)


                    Common Stock, par value $.004 per share
              ----------------------------------------------------
                         (Title of Class of Securities)


                                   053495305
              ----------------------------------------------------
                                 (CUSIP Number)
<PAGE>

CUSIP No. 053495305
- --------------------------------------------------------------------------------
1     Name of Reporting Person
      S.S. or I.R.S. Identification No. of Above Person

      David Berd, M.D.
 
- --------------------------------------------------------------------------------
2     Check the Appropriate Box If a Member of a Group
                                    a.  |_|
                                    b.  |_|
- --------------------------------------------------------------------------------
3     SEC Use Only

- --------------------------------------------------------------------------------
4     Citizenship or Place of Organization

      United States
- --------------------------------------------------------------------------------
                  5     Sole Voting Power
  Number of
   Shares               229,121
Beneficially            --------------------------------------------------------
  Owned By        6     Shared Voting Power
    Each
  Reporting             None
   Person               --------------------------------------------------------
    With          7     Sole Dispositive Power
 
                        229,121
                        --------------------------------------------------------
                  8     Shared Dispositive Power
 
                        None
                        --------------------------------------------------------

- --------------------------------------------------------------------------------
9     Aggregate Amount Beneficially Owned by Each Reporting Person

      229,121
- --------------------------------------------------------------------------------
10    Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares  |_|


- --------------------------------------------------------------------------------
11    Percent of Class Represented By Amount in Row (9)

      5.24%
- --------------------------------------------------------------------------------
12    Type of Reporting Person

      IN
- --------------------------------------------------------------------------------


                    SEE INSTRUCTIONS BEFORE FILLING OUT!


                                  Page 2 of 4
<PAGE>

ITEM 1(a).  NAME OF ISSUER:
            AVAX Technologies, Inc.

ITEM 1(b).  ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
            4520 Main Street, Suite 930
            Kansas City, MO 64111

ITEM 2(a).  NAME OF PERSON FILING:
            David Berd, M.D.

ITEM 2(b).  ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
            c/o Thomas Jefferson University
            Office of Technology Transfer
            1020 Locust Transfer
            Philadelphia, PA 19107

ITEM 2(c).  CITIZENSHIP:
            United States

ITEM 2(d).  TITLE OF CLASS OF SECURITIES:
            Common Stock, par value $.004 per share

ITEM 2(e).  CUSIP NUMBER:
            053495305

ITEM 3.     IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 
            13d-2(b), CHECK WHETHER THE PERSON FILING IS A: 
            Not Applicable

ITEM 4.     OWNERSHIP

            (a)  AMOUNT BENEFICIALLY OWNED:
                 229,121 shares

            (b)  PERCENT OF CLASS:
                 5.24%

            (c)  NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
                 (i)    Sole power to vote or to direct the vote:
                        229,121 shares

                 (ii)   Shared power to vote or to direct the vote:
                        NONE

                 (iii)  Sole power to dispose or to direct the disposition of: 
                        229,121 shares

                 (iv)   Shared power to dispose or to direct the disposition of:
                        NONE

ITEM 5.     OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
            Not applicable


                                  Page 3 of 4
<PAGE>

ITEM 6.     OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
            Not applicable

ITEM 7.     IDENTIFICATION  AND  CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
            THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
            Not Applicable

ITEM 8.     IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
            Not Applicable

ITEM 9.     NOTICE OF DISSOLUTION OF GROUP
            Not Applicable

ITEM 10.    CERTIFICATION
            Not Applicable

                                        SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


Dated: February 17, 1998               /s/ David Berd, M.D.
                                       -------------------------------
                                       David Berd, M.D.


                                  Page 4 of 4



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission